BioNexus Gene Lab Corp. (BGLC)
0.25
-0.05 (-16.44%)
At close: Mar 28, 2025, 3:58 PM
0.26
1.96%
Pre-market: Mar 31, 2025, 07:20 AM EDT
BioNexus Gene Lab Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Net Income | -2.63M | -355.97K | 751.57K | 1.09M | -246.47K | 26.45K | -123.75K | -835 |
| Depreciation & Amortization | 108.42K | 105.42K | 108.22K | 101.6K | 53.33K | 40.61K | 15.03K | n/a |
| Stock-Based Compensation | 511.74K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -23.12K | -129.67K | 39.98K | 68.49K | -11.01K | -357.93K | n/a | n/a |
| Other Non-Cash Items | 589.31K | -38.81K | 11.62K | -745.38K | 129.55K | 528.04K | -382.62K | n/a |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 117.98K | 833.38K | -862.25K | 102.36K | -24.14K | -341.14K | 439.31K | n/a |
| Operating Cash Flow | -1.3M | 544.03K | 9.16K | 552.68K | -217.27K | -274.08K | 357.22K | -835 |
| Capital Expenditures | -149.4K | -54.17K | -3.16K | -421.62K | -12.82K | -39.62K | -314.82K | n/a |
| Acquisitions | n/a | n/a | n/a | 346.01K | n/a | n/a | -5M | n/a |
| Purchase of Investments | -320.73K | -511.71K | -515.84K | -108.63K | n/a | -12.08K | n/a | n/a |
| Sales Maturities Of Investments | 26.15K | n/a | 6.39K | 30.06K | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 61.41K | 115.38K | 22.04K | 1.47M | -12.82K | -12.08K | n/a | n/a |
| Investing Cash Flow | -382.58K | -450.5K | -490.57K | 1.32M | -12.82K | -51.7K | -5.31M | n/a |
| Debt Repayment | n/a | -34.04K | -26.3K | -4.95K | -16.78K | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | -115.38K | -22.04K | -6.31K | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 5.75M | n/a | -1.92K | n/a | -164.03K | 742.94K | 5.78M | 638.00 |
| Financial Cash Flow | 5.75M | 115.96K | -28.22K | -4.95K | -180.81K | 742.94K | 5.78M | 638.00 |
| Net Cash Flow | 3.81M | -5.05K | -663.77K | 1.93M | -401.16K | 421.09K | 839.12K | -108 |
| Free Cash Flow | -1.45M | 489.86K | 6K | 131.06K | -230.09K | -313.7K | 42.4K | -835 |